PEStore

Buyout PE

Pencarrow Private Equity

Pencarrow Private Equity acquires controlling stakes in established, profitable businesses, from Auckland, New Zealand. It states a focus on healthcare & life sciences, consumer & retail and business & professional services.

Disclosed holdings24
Earliest stated investment
HeadquartersAuckland, New Zealand
Stated fund size$300 million

Stated investment criteria

What Pencarrow Private Equity says it buys

Read from Pencarrow Private Equity’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.

Enterprise value it states$20m to $150m1
Founded19932

A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. Pencarrow Private Equity states that it will take either a controlling or a minority stake. Nothing here is a commitment by Pencarrow Private Equity to consider any particular business, and nothing on this page is represented as being for sale.

Portfolio

Disclosed holdings

Companies Pencarrow Private Equity lists on its own website. No investment years are published.

CompanyInvestedYears heldRecorded transaction
Alleva
Alleva Animal Health
Avanti Finance
Belltea
Essano
Frostboss
Icebreaker
Mmcnz
Netlogix
Netlogixgroup
New Zealand Frost Fans
Pacific Clinical Research Network
Pcrn
Pet Direct
RedShield
Seequent
Shoof International
Shoofint
Skin Institute
Tend
The Collective
Thebegroup
Theinteriorsgroup
Umbrellar

Compiled from Pencarrow Private Equity’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Pencarrow Private Equity?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other buyout pe investors active in healthcare & life sciences.